-
Bictegravir (INN; BIC,
formerly known as GS-9883) is a second-generation
integrase inhibitor (INSTI)
class that was
structurally derived from an earlier...
-
Bictegravir/emtricitabine/tenofovir alafenamide, sold
under the
brand name Biktarvy, is a fixed-dose
combination antiretroviral medication for the treatment...
-
endonuclease inhibitor 2018
Biktarvy (
Bictegravir/emtricitabine/tenofovir alafenamide) HIV
Gilead Sciences Bictegravir:
INSTI Emtricitabine: NRTI Tenofovir...
- the US in 2013, and in the EU in
January 2014. The
combination drug
bictegravir/emtricitabine/tenofovir
alafenamide (Biktarvy),
produced by
Gilead Sciences...
- 2024. "The
Medicines Patent Pool and
Gilead Sciences Sign
Licence for
Bictegravir". The
Medicines Patent Pool. 4
October 2017.
Prize Committee Virchow...
-
approved in the
United States for HIV-1 pre-exposure
prophylaxis (PrEP).
Bictegravir/emtricitabine/tenofovir
alafenamide (Biktarvy) —
approved in the United...
-
Integrase inhibitors (Integrase
strand transfer inhibitors (INSTI))
Bictegravir (BIC)
Cabotegravir (CAB)
Dolutegravir (DTG)#
Elvitegravir (EVG) Raltegravir...
-
alafenamide and
rilpivirine J05AR20 Emtricitabine,
tenofovir alafenamide and
bictegravir J05AR21
Dolutegravir and
rilpivirine J05AR22 Emtricitabine, tenofovir...
-
Integrase inhibitors (Integrase
strand transfer inhibitors (INSTI))
Bictegravir (BIC)
Cabotegravir (CAB)
Dolutegravir (DTG)#
Elvitegravir (EVG) Raltegravir...
-
clinically approved integrase inhibitors are elvitegravir, dolutegravir,
bictegravir, and cabotegravir.
Protease inhibitors block the
viral protease enzyme...
